 SAN DIEGO, Jan. 31, 2022 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter fiscal year 2022, ended December 31, 2021, at 4:15 p.m. EST on Monday, February 14, 2022. 